U.S. Markets open in 4 hrs.

IntelliPharmaCeutics International Inc. (IPCI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.94-0.01 (-0.51%)
At close: 4:00PM EDT
People also watch
CPRXIDRAAPRIBLRXINFI
Interactive chart
Previous Close1.95
Open1.98
Bid1.65 x 500
Ask2.39 x 300
Day's Range1.93 - 1.98
52 Week Range1.41 - 3.35
Volume56,041
Avg. Volume215,430
Market Cap57.52M
BetaN/A
PE Ratio (TTM)-5.42
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Intellipharmaceutics International, Inc. :IPCI-US: Earnings Analysis: Q1, 2017 By the Numbers : April 14, 2017
    Capital Cube2 months ago

    Intellipharmaceutics International, Inc. :IPCI-US: Earnings Analysis: Q1, 2017 By the Numbers : April 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Intellipharmaceutics International, Inc. reports financial results for the quarter ended February 28, 2017. Highlights Summary numbers: Revenues of USD 1.24 million, Net Earnings of USD -1.99 million. Change in operating cash flow of 3.57% compared to same period last year is about the same as change in earnings, likely no significant ... Read more (Read more...)

  • IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected
    Zacks2 months ago

    IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected

    IntelliPharmaCeutics International Inc. (IPCI) reported loss of 7 cents per share in the first quarter of 2017, narrower than both the Zacks Consensus Estimate of a loss of 8 cents and the year-ago loss of 9 cents per share.

  • Associated Press2 months ago

    Intellipharmaceutics reports 1Q loss

    The Toronto-based company said it had a loss of 7 cents per share. The extended-release drug developer posted revenue of $1.2 million in the period. In the final minutes of trading on Tuesday, the company's ...